Legal status by country
Is Visepegenatide legal?
Written by Aaron CuhaReviewed Sep 2026
How Visepegenatide is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | No FDA approval. A phase 2 study was conducted in the United States; the phase 3 was run entirely in China. | No MHRA licence located. | Not registered with the TGA. | No Health Canada submission located. |
US FDA status: Not approved in the United States. Reported approved in China in November 2025 after the published phase 3; this site has not resolved a Chinese regulatory document, so treat the approval date as reported rather than as verified here.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.